IntrinsiQ launches IntelliDose 3.8
IntrinsiQ, the expert source of oncology insight, today launches IntelliDose 3.8, creating an intuitive new user experience to manage and track increasingly complex chemotherapy regimens.
IBM on February 16 announced it has acquired Intelliden Inc., one of the leading providers of intelligent network automation software that enables organizations such as telecommunications companies to configure, manage and scale their networks.